SIZE

RESEARCH

MARKET

DEMAND

BEAM

FORECAST

RESEARCH

AND

SIZE
AND

& RESEARCH
RESEARCH

Global Biosimilars/Follow-on-Biologics
Market (Technology, Types, Applications,
Services and Geography) 2013-2020

MARKET

SIZE

RESEARCH

MARKET

DEMAND

FORECAST

RESEARCH

AND

SIZE
AND

& RESEARCH
RESEARCH

FORECAST

TELEPHONE: +1 (855) 711-1555

E-MAIL: sales@researchbeam.com

Report Overview
Biosimilars or follow-on-biologics are the copied version of
reference biologics, which are protected by intellectual rights
that will expire soon. Patent expiration is the major driving
factor of the biosimilars market. Most of the blockbuster
patents will expire by the end of 2014, which would provide a
competitive edge to local pharmaceutical manufacturers over
the global players. For instance, patents for insulin glargine will
expire by the end of this year, which would give an opportunity
for the growth of insulin biosimilars market. Global
biosimilars/follow-on-biologics market accounted for $1,358
million in 2013 and it is anticipated to generate $35,032 million
by 2020, growing at a CAGR of 60.8% from 2014 to 2020.

Browse Complete Study Report at:

http://www.researchbeam.com/biosimilars-market

Report Overview
Regulations for biosimilars plays a vital role in maintaining the
viability and balance between original and biosimilar products.
Various regulatory authorities, namely EMA and the U.S. FDA
are actively regulating the biosimilars market. Regulations in the
European union are considered benchmark around the world,
as the guidelines proposed are most stringent for validation and
commercialization of biosimilars. High profitability is the
attractive aspect that is enticing companies to invest in the
biosimilars industry.
Geographically, Biosimilars market is segmented into North
America, Europe, Asia-Pacific and LAMEA. Due to favorable
regulatory policies designed by the European Medical
Association, the European market has been maximizing on the
biosimilars market. Asia-Pacific and LAMEA market would
witness a substantial rise in the use of biosimilars, as the
demand for cost effective treatment is growing due to the
prevalence of chronic diseases.

Report Overview
Key Benefits

The study is segmented in a strategic divisions to gain

deeper insights into the market dynamics and understand
the competitive environment of the overall market
Financial market forecast is provided for the next eight
years by considering 2013 as the base year
Comprehensive and quantitative data about changing
market trends, intensifying competition and opportunities in
biosimilars market are provided to make better business
decisions
Porters Five Forces model and SWOT analysis of the
overall market is provided to help stakeholders gain strategic
insights of the market
Deep dive analysis of key market players and strategies
adopted by them are expounded to provide valuable
information on the top contenders in the market
Identification of key investment pockets for the biosimilars
market is strategically dealt to assist the stakeholders

Report Overview
Key Deliverables
Global biosimilars/follow-on-biologics market is categorized into
technology, product types, applications, services and
geography.
MARKET BY TECHNOLOGY

Monoclonal Antibodies (MAb) Technology

Recombinant DNA Technology (rDNA technology)
Nuclear magnetic resonance (NMR) technology
Chromatography
Electrophoresis
Mass Spectrometry
Western Blotting
Bioassay

Enquire About Report: http://www.researchbeam.com/biosimilarsmarket/enquire-about-report

Tables of Contents
CHAPTER 1 INTRODUCTION
1.1 Key Benefits
1.2 Key Market Segment
1.3 Key Audiences
1.3.1 Research Methodology
1.3.2 Primary Research
1.3.3 Secondary Research
1.3.4 Analyst tools and models
CHAPTER 2 EXECUTIVE SUMMARY
2.1 CXO perspective
2.2 Market beyond: what to expect by 2025
2.2.1 Moderate growth scenario
2.2.2 Rapid growth scenario
2.2.3 Diminishing growth scenario

Similar Market Reports

Critical Pharmaceuticals Limited - Pharmaceuticals &
Healthcare - Deals and Alliances Profile
http://www.researchbeam.com/critical-pharmaceuticalslimited-pharmaceuticals-and-healthcare-deals-and-alliancesprofile-market
Bristol-Myers Squibb Company (BMY) - Financial and
Strategic SWOT Analysis Review
http://www.researchbeam.com/bristol-myers-squibb-companybmy-financial-and-strategic-swot-analysis-review-market
Metastatic Hepatocellular Carcinoma (HCC) - Pipeline
Review, H1 2015
http://www.researchbeam.com/metastatic-hepatocellularcarcinoma-hcc-pipeline-review-h1-2015-market

Contact

Visit us at :
http://www.researchbeam.com/biosimilars-market

TELEPHONE: +1 (855) 711-1555

E-MAIL: help@researchbeam.com

5933 NE Win Sivers Drive,

#205, Portland, OR 97220
United States